Toggle navigation
News
OK
NewsOK
News
Weather
Opinion
Business
Sports
Life
Photos
Videos
Brandinsight
Shopping
Classifieds
Homes
Jobs
Cars
Legals
Shop
Account
Settings
Subscribe
Contact Us
Support
Privacy Policy
Terms of Use
About our ads
Advertise with us
The Oklahoman
Market Watch
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
NewsOK Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Abeona Therapeutics
(NQ:
ABEO
)
2.240
USD
-0.090 (-3.86%)
Official Closing Price
Updated: 4:33 PM EST, Jan 26, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Abeona Therapeutics
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Abeona Therapeutics Receives Orphan Drug Designation in The European Union for ABO-101 Gene Therapy in Sanfilippo Syndrome Type B
January 18, 2017
From
GlobeNewswire News Releases
IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Abeona Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm
January 18, 2017
From
ACCESSWIRE
Lifshitz & Miller Law Firm Announces Investigation of Abeona Therapeutics Inc., Agile Therapeutics, Inc., Alere Inc., Floteck Industries, Inc., Insys Therapeutics Inc., MTS Systems Corporation, Ophtho
January 18, 2017
From
PR Newswire
INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Abeona Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm
January 18, 2017
From
ACCESSWIRE
Lawsuit for Investors in shares of Abeona Therapeutics Inc (NASDAQ:ABEO) announced by Shareholders Foundation
January 18, 2017
The Shareholders Foundation, Inc. announces that a lawsuit was filed in New York on behalf of certain purchasers of shares of Abeona Therapeutics Inc (NASDAQ:ABEO) over alleged Securities Laws...
From
GlobeNewswire News Releases
Abeona Therapeutics to Present at Phacilitate Cell & Gene Therapy World 2017
January 16, 2017
Company CEO to Present on Friday, January 20th at 12:40 pm EST
From
GlobeNewswire News Releases
INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Abeona Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm
January 16, 2017
From
ACCESSWIRE
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Abeona Therapeutics Inc. (ABEO) and Lead Plaintiff Deadline - February 14, 2017
January 16, 2017
From
ACCESSWIRE
SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Abeona Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm
January 12, 2017
From
ACCESSWIRE
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Abeona Therapeutics Inc. (ABEO) and Lead Plaintiff Deadline: February 14, 2017
January 12, 2017
From
ACCESSWIRE
EQUITY ALERT: Khang & Khang LLP Announces an Investigation of Abeona Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm
January 11, 2017
From
ACCESSWIRE
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Abeona Therapeutics Inc. (ABEO) To Contact Brower Piven Before The Lead Plaintiff Deadline
January 10, 2017
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been filed against Abeona Therapeutics Inc. (“Abeona” or the “Company”)...
From
GlobeNewswire News Releases
INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Abeona Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm
January 10, 2017
From
ACCESSWIRE
ABEO SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Abeona Therapeutics Inc. and a Lead Plaintiff Deadline of February 14, 2017
January 10, 2017
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased PlasmaTech...
From
GlobeNewswire News Releases
INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Abeona Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm
January 06, 2017
From
ACCESSWIRE
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Abeona Therapeutics Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 14, 2017 – ABEO
January 05, 2017
The following statement is being issued by Levi & Korsinsky, LLP:
From
GlobeNewswire News Releases
INVESTOR LOSS ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Abeona Therapeutics Inc. - ABEO
January 05, 2017
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of: (1) PlasmaTech Biopharmaceuticals, Inc. securities from March 31, 2015...
From
GlobeNewswire News Releases
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Abeona Therapeutics Inc. (ABEO) & Lead Plaintiff Deadline: February 14, 2017
January 05, 2017
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Abeona Therapeutics Inc. (“Abeona” or the “Company”) (NASDAQ:ABEO) and...
From
GlobeNewswire News Releases
The Life Sciences Report Announces 19 Companies Selected for the 2017 Small-Cap Biotech Watchlist
January 05, 2017
From
Marketwired News Releases
SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Abeona Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm
January 03, 2017
From
ACCESSWIRE
EQUITY ALERT: Khang & Khang LLP Announces an Investigation of Abeona Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm
January 03, 2017
From
ACCESSWIRE
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Abeona Therapeutics Inc. (ABEO) and Lead Plaintiff Deadline: February 14, 2017
January 03, 2017
From
ACCESSWIRE
Abeona Therapeutics Receives Orphan Drug Designation in The European Union for ABO-201 Gene Therapy Program in Juvenile Batten Disease
January 02, 2017
From
Marketwired News Releases
Abeona Therapeutics Receives Orphan Drug Designation in The European Union for ABO-201 Gene Therapy Program in Juvenile Batten Disease
January 02, 2017
From
Marketwired
INVESTOR ALERT: Lundin Law PC Announces an Investigation of Abeona Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm
December 29, 2016
From
ACCESSWIRE
INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Abeona Therapeutics Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Cla
December 28, 2016
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been filed against Abeona Therapeutics Inc. (“Abeona” or the “Company”)...
From
Business Wire News Releases
INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Abeona Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm
December 27, 2016
From
ACCESSWIRE
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Abeona Therapeutics Inc. (ABEO) and Lead Plaintiff Deadline: February 14, 2017
December 27, 2016
From
ACCESSWIRE
SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Abeona Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm
December 23, 2016
From
ACCESSWIRE
EQUITY ALERT: Rosen Law Firm Reminds Abeona Therapeutics Inc. Investors of Important Deadline in Class Action
December 23, 2016
Rosen Law Firm Representing Abeona Therapeutics Inc. Shareholders in Securities Class Action Lawsuit Seeking to Recover Investor Losses - ABEO
From
Business Wire News Releases
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.